Search Login Register
copolymer 1
(glatiramer acetate)
Summary
Description:
Israeli drug (Teva Pharmaceutical); a synthetic polypeptide consisting of L-Ala, L-Glu, L-Lys, and L-Tyr; produces antigen-suppressor cells specific for myelin-based protein; potential drug for treating multiple sclerosis; TV-5010 has a molecular weight of 15-kDa
Also Known As:
glatiramer acetate; Copaxone; Aventis brand of copolymer 1; TV 5010; TV-5010 Show All >>
Networked: 744
relevant articles (92 outcomes,
147 trials/studies)
for this Drug
Key Diseases for which copolymer 1 is
Relevant
-
Multiple Sclerosis
:
45 outcomes 80 studies in 474 results
-
Relapsing-Remitting Multiple Sclerosis
:
22 outcomes 46 studies in 192 results
-
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
:
17 outcomes 5 studies in 79 results
-
Disease Progression
:
4 outcomes 7 studies in 21 results
-
Fatigue
:
3 outcomes 3 studies in 10 results
Show All >>
Drugs Related to copolymer 1
-
copolymer 1 (glatiramer acetate)
-
Interferon-beta
-
Interferons
-
Mitoxantrone (Novantrone)
-
Amino Acids
-
natalizumab (Tysabri)
-
interferon beta-1b (Betaseron)
-
Minocycline (Cyclops)
-
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
-
HLA-DR2 Antigen (HLA DR2 Antigen)
Show All >>
Therapies Related to copolymer 1
-
Immunomodulation
-
Injections
-
Immunotherapy
-
Lasers (Laser)
-
Subcutaneous Injections
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.